Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Trisul |
Active Ingredients: |
Sulfamethoxazole 400mg Trimethoprim 80mg |
Dosage Form: | Tablet |
New Zealand Sponsor: | Mylan New Zealand Limited |
Manufacturers: |
Intas Pharmaceuticals Limited, Sanand, India Alphapharm Pty Limited, Brisbane, Australia |
Product: | Zavicefta |
Active Ingredients: |
Avibactam sodium 543.5mg equivalent to avibactam 500mg Ceftazidime pentahydrate 2329.7mg equivalent to ceftazidime 2000mg |
Dosage Form: | Powder for infusion concentrate |
New Zealand Sponsor: | Pfizer New Zealand Limited |
Manufacturer: | ACS Dobfar SpA, Verona, Italy |
Dated this 31st day of May 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).